Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
A Randomized Phase II Study of AGS-16C3F Versus Axitinib in Previously Treated Patients With Metastatic Renal Cell CarcinomaOncologist 2020 Dec 08;[EPub Ahead of Print], C Kollmannsberger, TK Choueiri, DYC Heng, S George, F Jie, R Croitoru, S Poondru, JA Thompson
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.